NorthCoast Asset Management’s Amedisys AMED Stock Holding History

NorthCoast Asset Management’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-5,485	Closed	-$676K	–	254
2019 Q1	$676K	Buy	+5,485	New	+$688K	0.04%	175
2018 Q2	–	Sell	-16,255	Closed	-$981K	–	178
2018 Q1	$981K	Sell	16,255 -165	-1%	-$9.4K	0.09%	128
2017 Q4	$865K	Buy	16,420 +11,736	+251%	+$618K	0.08%	139
2017 Q3	$262K	Buy	+4,684	New	+$248K	0.03%	148
2016 Q3	–	Sell	-8,214	Closed	-$415K	–	157
2016 Q2	$415K	Buy	8,214 +1,260	+18%	+$63.6K	0.03%	158
2016 Q1	$336K	Sell	6,954 -333	-5%	-$12.8K	0.03%	120
2015 Q4	$287K	Buy	7,287 +673	+10%	+$26.9K	0.02%	135
2015 Q3	$251K	Buy	+6,614	New	+$279K	0.01%	132

Other funds holding AMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

NorthCoast Asset Management's AMED Position: Q2 2019 in Review

NorthCoast Asset Management sold out of Amedisys (AMED) in Q2 2019, closing a stake of 5,485 shares — an estimated $676K sold.

NorthCoast Asset Management first reported a position in AMED in Q3 2015 and held it in 8 quarters. The position peaked at $981K in Q1 2018. 285 funds tracked by Wall St. Rank hold AMED as of Q2 2019.

NorthCoast Asset Management reported no remaining Amedisys position as of Q2 2019 after selling out during the quarter.
NorthCoast Asset Management sold 5,485 Amedisys shares in Q2 2019, an estimated $676K.
NorthCoast Asset Management first reported a position in Amedisys in Q3 2015 and held it in 8 quarters.
NorthCoast Asset Management's Amedisys position peaked at $981K in Q1 2018.
285 funds tracked by Wall St. Rank held Amedisys as of Q2 2019.

Based on NorthCoast Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.